Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.
2.

Influence of health insurance status on childhood cancer treatment outcomes in Kenya.

Olbara G, Martijn HA, Njuguna F, Langat S, Martin S, Skiles J, Vik T, Kaspers GJL, Mostert S.

Support Care Cancer. 2020 Feb;28(2):917-924. doi: 10.1007/s00520-019-04859-1. Epub 2019 Jun 7.

PMID:
31172285
3.

Health-care providers' perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya.

Olbara G, Parigger J, Njuguna F, Skiles J, Sitaresmi MN, Gordijn S, van de Ven P, Kaspers G, Mostert S.

Pediatr Blood Cancer. 2018 Dec;65(12):e27309. doi: 10.1002/pbc.27309. Epub 2018 Jul 26.

PMID:
30051647
4.

Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in Kenya.

Mostert S, Njuguna F, van der Burgt RHM, Musimbi J, Langat S, Skiles J, Seijffert A, Sitaresmi MN, Vik TA, van de Ven PM, Kaspers GJL.

Pediatr Blood Cancer. 2018 Aug;65(8):e27221. doi: 10.1002/pbc.27221. Epub 2018 May 9.

PMID:
29741267
5.

Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya.

Martijn HA, Njuguna F, Olbara G, Langat S, Skiles J, Martin S, Vik T, van de Ven PM, Kaspers GJ, Mostert S.

BMJ Paediatr Open. 2017 Aug 11;1(1):e000149. doi: 10.1136/bmjpo-2017-000149. eCollection 2017.

6.

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.

Skiles JL, Chiang C, Li CH, Martin S, Smith EL, Olbara G, Jones DR, Vik TA, Mostert S, Abbink F, Kaspers GJ, Li L, Njuguna F, Sajdyk TJ, Renbarger JL.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26854. Epub 2017 Nov 8.

7.

Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income Setting.

Njuguna F, Martijn HA, Kuremu RT, Saula P, Kirtika P, Olbara G, Langat S, Martin S, Skiles J, Vik T, Kaspers GJL, Mostert S.

J Glob Oncol. 2016 Dec 21;3(5):555-562. doi: 10.1200/JGO.2016.005389. eCollection 2017 Oct.

8.

The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.

Mostert S, Petzer A, Petzer JP.

Eur J Med Chem. 2017 Jul 28;135:196-203. doi: 10.1016/j.ejmech.2017.04.055. Epub 2017 Apr 22.

PMID:
28456030
9.

Health-Care Providers' Perspectives towards Childhood Cancer Treatment in Kenya.

Njuguna F, van der Burgt RH, Seijffert A, Musimbi J, Langat S, Skiles J, Sitaresmi MN, van de Ven PM, Kaspers GJ, Mostert S.

Asian Pac J Cancer Prev. 2016;17(9):4445-4450.

10.

Delays in diagnosis and treatment of childhood cancer in Indonesia.

Handayani K, Sitaresmi MN, Supriyadi E, Widjajanto PH, Susilawati D, Njuguna F, van de Ven PM, Kaspers GJ, Mostert S.

Pediatr Blood Cancer. 2016 Dec;63(12):2189-2196. doi: 10.1002/pbc.26174. Epub 2016 Aug 11.

PMID:
27510358
11.

HealthCare Providers' and Parents' Perspectives on Complementary Alternative Medicine in Children with Cancer in Indonesia.

Susilawati D, Sitaresmi M, Handayani K, Ven Pv, Sutaryo, Kaspers G, Mostert S.

Asian Pac J Cancer Prev. 2016;17(7):3235-42.

12.

Parental Experiences with Chemotherapy-Induced Alopecia among Childhood Cancer Patients in Indonesia.

Gunawan S, Broeke CT, Ven Pv, Arnoldussen M, Kaspers G, Mostert S.

Asian Pac J Cancer Prev. 2016;17(4):1717-23.

13.

Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya.

Njuguna F, Martijn H, Langat S, Musimbi J, Muliro H, Skiles J, Vik T, Sitaresmi MN, van de Ven PM, Kaspers GJ, Mostert S.

Pediatr Hematol Oncol. 2016 Apr;33(3):186-99. doi: 10.3109/08880018.2016.1169566.

14.

Inhibition of monoamine oxidase by benzoxathiolone analogues.

Mostert S, Petzer A, Petzer JP.

Bioorg Med Chem Lett. 2016 Feb 15;26(4):1200-4. doi: 10.1016/j.bmcl.2016.01.034. Epub 2016 Jan 16.

PMID:
26821818
15.

Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.

Mostert S, Petzer A, Petzer JP.

Chem Biol Drug Des. 2016 May;87(5):737-46. doi: 10.1111/cbdd.12708. Epub 2016 Jan 12.

PMID:
26684482
16.

Hospital detention practices: statement of a global taskforce.

Mostert S, Lam CG, Njuguna F, Patenaude AF, Kulkarni K, Salaverria C; SIOP PODC Global Taskforce on Hospital Detention Practices.

Lancet. 2015 Aug 15;386(9994):649. doi: 10.1016/S0140-6736(15)61495-7. No abstract available.

17.

Comparing Health-Care Providers' Perspectives on Complementary and Alternative Medicine in Childhood Cancer Between Netherlands and Indonesia.

Gunawan S, Arnoldussen M, Gordijn MS, Sitaresmi MN, van de Ven PM, Ten Broeke CA, Veerman AJ, Mantik M, Kaspers GJ, Mostert S.

Pediatr Blood Cancer. 2016 Jan;63(1):118-23. doi: 10.1002/pbc.25689. Epub 2015 Aug 14.

PMID:
26274831
18.

Corruption in health-care systems and its effect on cancer care in Africa.

Mostert S, Njuguna F, Olbara G, Sindano S, Sitaresmi MN, Supriyadi E, Kaspers G.

Lancet Oncol. 2015 Aug;16(8):e394-404. doi: 10.1016/S1470-2045(15)00163-1. Review.

PMID:
26248847
19.

Indanones as high-potency reversible inhibitors of monoamine oxidase.

Mostert S, Petzer A, Petzer JP.

ChemMedChem. 2015 May;10(5):862-73. doi: 10.1002/cmdc.201500059. Epub 2015 Mar 27.

PMID:
25820651
20.

Parental experiences of childhood cancer treatment in Kenya.

Njuguna F, Mostert S, Seijffert A, Musimbi J, Langat S, van der Burgt RH, Skiles J, Sitaresmi MN, van de Ven PM, Kaspers GJ.

Support Care Cancer. 2015 May;23(5):1251-9. doi: 10.1007/s00520-014-2475-x. Epub 2014 Oct 17.

PMID:
25318695
21.

Parents' and health-care providers' perspectives on side- effects of childhood cancer treatment in Indonesia.

Gunawan S, Wolters E, van Dongen J, van de Ven P, Sitaresmi M, Veerman A, Mantik M, Kaspers G, Mostert S.

Asian Pac J Cancer Prev. 2014;15(8):3593-9.

22.

Two overlooked contributors to abandonment of childhood cancer treatment in Kenya: parents' social network and experiences with hospital retention policies.

Mostert S, Njuguna F, Langat SC, Slot AJ, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Vreeman RC, Kaspers GJ.

Psychooncology. 2014 Jun;23(6):700-7. doi: 10.1002/pon.3571. Epub 2014 May 1.

PMID:
24789661
23.

Abandonment of childhood cancer treatment in Western Kenya.

Njuguna F, Mostert S, Slot A, Langat S, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Muliro H, Vreeman RC, Kaspers GJ.

Arch Dis Child. 2014 Jul;99(7):609-14. Epub 2014 Mar 28.

PMID:
24681695
24.

Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya.

Mostert S, Njuguna F, van de Ven PM, Olbara G, Kemps LJ, Musimbi J, Strother RM, Aluoch LM, Skiles J, Buziba NG, Sitaresmi MN, Vreeman RC, Kaspers GJ.

Pediatr Blood Cancer. 2014 May;61(5):913-8. doi: 10.1002/pbc.24896. Epub 2013 Dec 17.

PMID:
24347434
25.

A medication diary-book for pediatric patients with acute lymphoblastic leukemia in Indonesia.

Sitaresmi MN, Mostert S, Gundy CM, Ismail D, Veerman AJ.

Pediatr Blood Cancer. 2013 Oct;60(10):1593-7. doi: 10.1002/pbc.24570. Epub 2013 Jun 3.

PMID:
23733528
26.

Health-care providers' perspectives on childhood cancer treatment in Manado, Indonesia.

Mostert S, Gunawan S, van Dongen JA, van de Ven PM, Sitaresmi MN, Wolters EE, Veerman AJ, Mantik M, Kaspers GJ.

Psychooncology. 2013 Nov;22(11):2522-8. doi: 10.1002/pon.3314. Epub 2013 May 23.

PMID:
23703746
27.

Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.

Mostert S, Mentz W, Petzer A, Bergh JJ, Petzer JP.

Bioorg Med Chem. 2012 Dec 15;20(24):7040-50. doi: 10.1016/j.bmc.2012.10.005. Epub 2012 Oct 16.

PMID:
23122934
28.

Epidemiology of diagnosed childhood cancer in Western Kenya.

Mostert S, Njuguna F, Kemps L, Strother M, Aluoch L, Buziba G, Kaspers G.

Arch Dis Child. 2012 Jun;97(6):508-12. doi: 10.1136/archdischild-2011-300829. Epub 2012 Apr 25.

PMID:
22535237
29.

Socio-economic status plays important roles in childhood cancer treatment outcome in Indonesia.

Mostert S, Gunawan S, Wolters E, van de Ven P, Sitaresmi M, Dongen Jv, Veerman A, Mantik M, Kaspers G.

Asian Pac J Cancer Prev. 2012;13(12):6491-6.

30.

Effect of corruption on medical care in low-income countries.

Mostert S, Sitaresmi MN, Njuguna F, van Beers EJ, Kaspers GJ.

Pediatr Blood Cancer. 2012 Mar;58(3):325-6. doi: 10.1002/pbc.23408. Epub 2011 Nov 21. No abstract available.

PMID:
22106048
31.

Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group.

Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, Kaur G, Koodiyedath B, Kulkarni K, Lam CG, Luna-Fineman S, Pizer B, Rivas S, Rossell N, Sitaresmi MN, Tsimicalis A, Weaver M, Ribeiro RC.

Lancet Oncol. 2011 Aug;12(8):719-20. doi: 10.1016/S1470-2045(11)70128-0. Epub 2011 Jun 28. No abstract available.

PMID:
21719348
32.

Societal output and use of research performed by health research groups.

Mostert SP, Ellenbroek SP, Meijer I, van Ark G, Klasen EC.

Health Res Policy Syst. 2010 Oct 12;8:30. doi: 10.1186/1478-4505-8-30.

33.

Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.

Sitaresmi MN, Mostert S, Purwanto I, Gundy CM, Sutaryo, Veerman AJ.

J Pediatr Oncol Nurs. 2009 Jul-Aug;26(4):198-207. doi: 10.1177/1043454209340315.

PMID:
19726791
34.

Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia.

Mostert S, Sitaresmi MN, Gundy CM, Janes V, Sutaryo, Veerman AJ.

Arch Dis Child. 2010 Jan;95(1):20-5. doi: 10.1136/adc.2008.154138. Epub 2009 Aug 12.

PMID:
19679573
35.

Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences.

Sitaresmi MN, Mostert S, Schook RM; Sutaryo, Veerman AJ.

Psychooncology. 2010 Apr;19(4):361-7. doi: 10.1002/pon.1578.

PMID:
19434599
36.

Parental experiences of childhood leukemia treatment in indonesia.

Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.

J Pediatr Hematol Oncol. 2008 Oct;30(10):738-43. doi: 10.1097/MPH.0b013e31817e4aad.

PMID:
19011470
37.

Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia.

Sitaresmi MN, Mostert S, Gundy CM, Sutaryo, Veerman AJ.

Health Qual Life Outcomes. 2008 Nov 9;6:96. doi: 10.1186/1477-7525-6-96.

38.

Does aid reach the poor? Experiences of a childhood leukaemia outreach-programme.

Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.

Eur J Cancer. 2009 Feb;45(3):414-9. doi: 10.1016/j.ejca.2008.09.018. Epub 2008 Nov 6.

PMID:
18977652
39.

Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia.

Sitaresmi MN, Mostert S, Gundy CM, Sutaryo, Veerman AJ.

Pediatr Blood Cancer. 2008 Dec;51(6):732-6. doi: 10.1002/pbc.21698.

PMID:
18816641
40.

Attitude of health-care providers toward childhood leukemia patients with different socio-economic status.

Mostert S, Sitaresmi MN, Gundy CM; Sutaryo, Veerman AJ.

Pediatr Blood Cancer. 2008 May;50(5):1001-5.

PMID:
17676594
41.

Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.

Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.

Pediatrics. 2006 Dec;118(6):e1600-6. Epub 2006 Oct 30.

PMID:
17074838

Supplemental Content

Loading ...
Support Center